Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

dc.creatorLeFevre, Inge
dc.creatorBravo, Lulu
dc.creatorFolschweiller, Nicolas
dc.creatorMedina, Eduardo Lopez
dc.creatorMoreira Jr, Edson Duarte
dc.creatorNordio, Francesco
dc.creatorSharma, Mayuri
dc.creatorTharenos, Leslie M.
dc.creatorTricou, Vianney
dc.creatorWatanaveeradej, Veerachai
dc.creatorWinkle, Peter J.
dc.creatorBiswal, Shibadas
dc.date.accessioned2023-06-06T13:46:14Z
dc.date.accessioned2023-09-05T11:52:14Z
dc.date.available2023-06-06T13:46:14Z
dc.date.available2023-09-05T11:52:14Z
dc.date.created2023-06-06T13:46:14Z
dc.date.issued2023
dc.identifierLEFEVRE, Inge et al. Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults. npj Vaccines, v. 75, p. 1-9, 2023.
dc.identifier2059-0105
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/58942
dc.identifier10.1038/s41541-023-00670-6
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8644014
dc.languageeng
dc.publisherNature Research
dc.rightsopen access
dc.titleBridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults
dc.typeArticle


Este ítem pertenece a la siguiente institución